Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Haematologica|January 19, 2010
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myelomaJochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, et al.
Cell Death & Disease|February 5, 2021
The N-terminal BRCT domain determines MCPH1 function in brain development and fertilityXiaoqian Liu, Nadine Schneble-Löhnert, Martina Kristofova, et al.
Molecular Therapy. Methods & Clinical Development|March 24, 2020
Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in PatientsAlexander Kunz, Ulrike Gern, Anita Schmitt, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Analysis of HDACi-Coupled Nanoparticles: Opportunities and ChallengesMarie Kühne, Susanne Hofmann, Henry Lindemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
PRAME-induced inhibition of retinoic acid receptor signaling-mediated differentiation--a possible target for ATRA response in AML without t(15;17)Lars Bullinger, Richard F Schlenk, Marlies Götz, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 28, 2021
Stroke Angel: Effect of Telemedical Prenotification on In-Hospital Delays and Systemic Thrombolysis in Acute Stroke PatientsPatrick Andreas Eder, Gunter Laux, Asarnusch Rashid, et al.
International Journal of Cancer|April 28, 2015
Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigensVanessa Schneider, Lu Zhang, Markus Rojewski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2018
Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantationAntje Stolzenburg, Katharina Lückerath, Samuel Samnick, et al.
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Pageof 4